Physician profile
Gary M Mason
NPI 1033172481
$1,277.39
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.86 · 2020: $362 · 2021: $523 · 2022: $311.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $426.54 | 2019-2022 | |
| Novo Nordisk INC | $217.05 | 2020-2022 | |
| Lilly USA, LLC | $149.10 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $72.05 | 2020-2022 | |
| Amarin Pharma, INC. | $64.89 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.13 | 2022 | |
| Astellas Pharma US INC | $47.81 | 2021-2022 | |
| Janssen Biotech, INC. | $41.10 | 2021 | |
| Abbvie INC. | $38.00 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.65 | 2022 | |
| Amgen INC. | $30.38 | 2021-2022 | |
| Boston Scientific Corporation | $28.18 | 2019 | |
| Glaxosmithkline, LLC. | $25.67 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.87 | 2021 | |
| Xeris Pharmaceuticals, INC. | $12.50 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascend Therapeutics US, LLC | $11.82 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.65 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.